0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Medical Hemostatic Agents Market Report & Forecast 2023-2029
Published Date: December 2023
|
Report Code: QYRE-Auto-39P15976
Home | Market Reports | Health| Medical Devices & Equipment
Global and India Medical Hemostatic Agents Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Medical Hemostatic Agents Market Report & Forecast 2023-2029

Code: QYRE-Auto-39P15976
Report
December 2023
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Medical Hemostatic Agents Market Size

The global Medical Hemostatic Agents revenue was US$ 3500.1 million in 2022 and is forecast to a readjusted size of US$ 5079.9 million by 2029 with a CAGR of 5.4% during the forecast period (2023-2029).

and India Medical Hemostatic Agents Market

and India Medical Hemostatic Agents Market

Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.
In India, the Medical Hemostatic Agents revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.
This report focuses on global and India Medical Hemostatic Agents market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Medical Hemostatic Agents will continue to grow rapidly in the future.
Global Medical Hemostatic Agents Scope and Market Size
Medical Hemostatic Agents market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Medical Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Medical Hemostatic Agents market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Medical Hemostatic Agents Market Report

Report Metric Details
Report Name and India Medical Hemostatic Agents Market
Forecasted market size in 2029 US$ 5079.9 million
CAGR 5.4%
Forecasted years 2023 - 2029
Segment by Type
  • Gelation Hemostats
  • Combination Hemostats
  • Others
Segment by Application
  • Hospitals
  • Surgical Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company J&J, Baxter, BD, Gelita, Pfizer, B Braun, CSL Behring, Ferrosan Medical Devices, Advance Medical Solution, Medtronic, Z-Medica, Marine Polymer, Equimedical, CryoLife
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Medical Hemostatic Agents Market size in 2029?

Ans: The and India Medical Hemostatic Agents Market size in 2029 will be US$ 5079.9 million.

What is the and India Medical Hemostatic Agents Market share by region?

Ans: Then Europe is the second largest consumption region with the market share of about 30%. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

What is the J&J, Baxter, BD, Gelita, Pfizer, B Braun share in and India Medical Hemostatic Agents Market?

Ans: J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share.

Who are the main players in the and India Medical Hemostatic Agents Market report?

Ans: The main players in the and India Medical Hemostatic Agents Market are J&J, Baxter, BD, Gelita, Pfizer, B Braun, CSL Behring, Ferrosan Medical Devices, Advance Medical Solution, Medtronic, Z-Medica, Marine Polymer, Equimedical, CryoLife

What are the Application segmentation covered in the and India Medical Hemostatic Agents Market report?

Ans: The Applications covered in the and India Medical Hemostatic Agents Market report are Hospitals, Surgical Centers, Others

What are the Type segmentation covered in the and India Medical Hemostatic Agents Market report?

Ans: The Types covered in the and India Medical Hemostatic Agents Market report are Gelation Hemostats, Combination Hemostats, Others

Recommended Reports

Hemostatic Agents

Hemostatic Dressings & Sponges

Absorbable Hemostats

1 Study Coverage
1.1 Medical Hemostatic Agents Product Introduction
1.2 Global Medical Hemostatic Agents Outlook 2018 VS 2022 VS 2029
1.2.1 Global Medical Hemostatic Agents Sales in US$ Million for the Year 2018-2029
1.2.2 Global Medical Hemostatic Agents Sales in Volume for the Year 2018-2029
1.3 India Medical Hemostatic Agents Outlook 2018 VS 2022 VS 2029
1.3.1 India Medical Hemostatic Agents Sales in US$ Million for the Year 2018-2029
1.3.2 India Medical Hemostatic Agents Sales in Volume for the Year 2018-2029
1.4 Medical Hemostatic Agents Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Medical Hemostatic Agents in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Medical Hemostatic Agents Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Medical Hemostatic Agents Market Dynamics
1.5.1 Medical Hemostatic Agents Industry Trends
1.5.2 Medical Hemostatic Agents Market Drivers
1.5.3 Medical Hemostatic Agents Market Challenges
1.5.4 Medical Hemostatic Agents Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Medical Hemostatic Agents by Type
2.1 Medical Hemostatic Agents Market Segment by Type
2.1.1 Gelation Hemostats
2.1.2 Combination Hemostats
2.1.3 Others
2.2 Global Medical Hemostatic Agents Market Size by Type
2.2.1 Global Medical Hemostatic Agents Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Medical Hemostatic Agents Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Medical Hemostatic Agents Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Medical Hemostatic Agents Market Size by Type
2.3.1 India Medical Hemostatic Agents Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Medical Hemostatic Agents Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Medical Hemostatic Agents Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Medical Hemostatic Agents by Application
3.1 Medical Hemostatic Agents Market Segment by Application
3.1.1 Hospitals
3.1.2 Surgical Centers
3.1.3 Others
3.2 Global Medical Hemostatic Agents Market Size by Application
3.2.1 Global Medical Hemostatic Agents Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Medical Hemostatic Agents Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Medical Hemostatic Agents Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Medical Hemostatic Agents Market Size by Application
3.3.1 India Medical Hemostatic Agents Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Medical Hemostatic Agents Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Medical Hemostatic Agents Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Medical Hemostatic Agents Competitor Landscape by Company
4.1 Global Medical Hemostatic Agents Market Size by Company
4.1.1 Global Key Manufacturers of Medical Hemostatic Agents, Ranked by Revenue (2022)
4.1.2 Global Medical Hemostatic Agents Revenue by Manufacturer (2018-2023)
4.1.3 Global Medical Hemostatic Agents Sales by Manufacturer (2018-2023)
4.1.4 Global Medical Hemostatic Agents Price by Manufacturer (2018-2023)
4.2 Global Medical Hemostatic Agents Concentration Ratio (CR)
4.2.1 Medical Hemostatic Agents Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Medical Hemostatic Agents in 2022
4.2.3 Global Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Medical Hemostatic Agents, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Medical Hemostatic Agents, Product Offered and Application
4.5 Global Key Manufacturers of Medical Hemostatic Agents, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Medical Hemostatic Agents Market Size by Company
4.7.1 Key Players of Medical Hemostatic Agents in India, Ranked by Revenue (2022)
4.7.2 India Medical Hemostatic Agents Revenue by Players (2018-2023)
4.7.3 India Medical Hemostatic Agents Sales by Players (2018-2023)
5 Global Medical Hemostatic Agents Market Size by Region
5.1 Global Medical Hemostatic Agents Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Medical Hemostatic Agents Market Size in Volume by Region (2018-2029)
5.2.1 Global Medical Hemostatic Agents Sales in Volume by Region: 2018-2023
5.2.2 Global Medical Hemostatic Agents Sales in Volume Forecast by Region (2024-2029)
5.3 Global Medical Hemostatic Agents Market Size in Value by Region (2018-2029)
5.3.1 Global Medical Hemostatic Agents Sales in Value by Region: 2018-2023
5.3.2 Global Medical Hemostatic Agents Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Medical Hemostatic Agents Market Size YoY Growth 2018-2029
6.2 Americas Medical Hemostatic Agents Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Medical Hemostatic Agents Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Medical Hemostatic Agents Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Medical Hemostatic Agents Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Medical Hemostatic Agents Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Medical Hemostatic Agents Market Size YoY Growth 2018-2029
7.2 EMEA Medical Hemostatic Agents Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Medical Hemostatic Agents Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Medical Hemostatic Agents Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Medical Hemostatic Agents Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Medical Hemostatic Agents Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Medical Hemostatic Agents Market Size YoY Growth 2018-2029
8.2 China Medical Hemostatic Agents Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Medical Hemostatic Agents Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Medical Hemostatic Agents Market Size YoY Growth 2018-2029
9.2 APAC Medical Hemostatic Agents Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Medical Hemostatic Agents Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Medical Hemostatic Agents Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Medical Hemostatic Agents Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Medical Hemostatic Agents Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 J&J
10.1.1 J&J Company Information
10.1.2 J&J Description and Business Overview
10.1.3 J&J Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.1.4 J&J Medical Hemostatic Agents Products Offered
10.1.5 J&J Recent Development
10.2 Baxter
10.2.1 Baxter Company Information
10.2.2 Baxter Description and Business Overview
10.2.3 Baxter Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter Medical Hemostatic Agents Products Offered
10.2.5 Baxter Recent Development
10.3 BD
10.3.1 BD Company Information
10.3.2 BD Description and Business Overview
10.3.3 BD Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BD Medical Hemostatic Agents Products Offered
10.3.5 BD Recent Development
10.4 Gelita
10.4.1 Gelita Company Information
10.4.2 Gelita Description and Business Overview
10.4.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Gelita Medical Hemostatic Agents Products Offered
10.4.5 Gelita Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Description and Business Overview
10.5.3 Pfizer Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Medical Hemostatic Agents Products Offered
10.5.5 Pfizer Recent Development
10.6 B Braun
10.6.1 B Braun Company Information
10.6.2 B Braun Description and Business Overview
10.6.3 B Braun Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.6.4 B Braun Medical Hemostatic Agents Products Offered
10.6.5 B Braun Recent Development
10.7 CSL Behring
10.7.1 CSL Behring Company Information
10.7.2 CSL Behring Description and Business Overview
10.7.3 CSL Behring Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.7.4 CSL Behring Medical Hemostatic Agents Products Offered
10.7.5 CSL Behring Recent Development
10.8 Ferrosan Medical Devices
10.8.1 Ferrosan Medical Devices Company Information
10.8.2 Ferrosan Medical Devices Description and Business Overview
10.8.3 Ferrosan Medical Devices Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Ferrosan Medical Devices Medical Hemostatic Agents Products Offered
10.8.5 Ferrosan Medical Devices Recent Development
10.9 Advance Medical Solution
10.9.1 Advance Medical Solution Company Information
10.9.2 Advance Medical Solution Description and Business Overview
10.9.3 Advance Medical Solution Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Advance Medical Solution Medical Hemostatic Agents Products Offered
10.9.5 Advance Medical Solution Recent Development
10.10 Medtronic
10.10.1 Medtronic Company Information
10.10.2 Medtronic Description and Business Overview
10.10.3 Medtronic Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Medtronic Medical Hemostatic Agents Products Offered
10.10.5 Medtronic Recent Development
10.11 Z-Medica
10.11.1 Z-Medica Company Information
10.11.2 Z-Medica Description and Business Overview
10.11.3 Z-Medica Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Z-Medica Medical Hemostatic Agents Products Offered
10.11.5 Z-Medica Recent Development
10.12 Marine Polymer
10.12.1 Marine Polymer Company Information
10.12.2 Marine Polymer Description and Business Overview
10.12.3 Marine Polymer Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Marine Polymer Medical Hemostatic Agents Products Offered
10.12.5 Marine Polymer Recent Development
10.13 Equimedical
10.13.1 Equimedical Company Information
10.13.2 Equimedical Description and Business Overview
10.13.3 Equimedical Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Equimedical Medical Hemostatic Agents Products Offered
10.13.5 Equimedical Recent Development
10.14 CryoLife
10.14.1 CryoLife Company Information
10.14.2 CryoLife Description and Business Overview
10.14.3 CryoLife Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
10.14.4 CryoLife Medical Hemostatic Agents Products Offered
10.14.5 CryoLife Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Medical Hemostatic Agents Industry Chain Analysis
11.2 Medical Hemostatic Agents Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Medical Hemostatic Agents Production Mode & Process
11.4 Medical Hemostatic Agents Sales and Marketing
11.4.1 Medical Hemostatic Agents Sales Channels
11.4.2 Medical Hemostatic Agents Distributors
11.5 Medical Hemostatic Agents Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Medical Hemostatic Agents CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Medical Hemostatic Agents Market Trends
    Table 3. Medical Hemostatic Agents Market Drivers
    Table 4. Medical Hemostatic Agents Market Challenges
    Table 5. Medical Hemostatic Agents Market Restraints
    Table 6. Global Medical Hemostatic Agents Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Medical Hemostatic Agents Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Medical Hemostatic Agents Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Medical Hemostatic Agents Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Medical Hemostatic Agents, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Medical Hemostatic Agents Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Medical Hemostatic Agents Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Medical Hemostatic Agents Sales by Manufacturer, (K Units), 2018-2023
    Table 14. Global Medical Hemostatic Agents Sales Share by Manufacturer, 2018-2023
    Table 15. Global Medical Hemostatic Agents Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 16. Global Medical Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Medical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Hemostatic Agents as of 2022)
    Table 18. Global Key Manufacturers of Medical Hemostatic Agents, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Medical Hemostatic Agents, Product Offered and Application
    Table 20. Global Key Manufacturers of Medical Hemostatic Agents, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Medical Hemostatic Agents in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Medical Hemostatic Agents Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Medical Hemostatic Agents Revenue Share by Players, (2018-2023)
    Table 25. India Medical Hemostatic Agents Sales by Players, (K Units), (2018-2023)
    Table 26. India Medical Hemostatic Agents Sales Share by Players, (2018-2023)
    Table 27. Global Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Medical Hemostatic Agents Sales in Volume by Region (2018-2023) & (K Units)
    Table 29. Global Medical Hemostatic Agents Sales in Volume Forecast by Region (2024-2029) & (K Units)
    Table 30. Global Medical Hemostatic Agents Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Medical Hemostatic Agents Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Medical Hemostatic Agents Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Medical Hemostatic Agents Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Medical Hemostatic Agents Sales in Volume by Country (2018-2023) & (K Units)
    Table 36. Americas Medical Hemostatic Agents Sales in Volume by Country (2024-2029) & (K Units)
    Table 37. EMEA Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Medical Hemostatic Agents Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Medical Hemostatic Agents Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Medical Hemostatic Agents Sales in Volume by Country (2018-2023) & (K Units)
    Table 41. EMEA Medical Hemostatic Agents Sales in Volume by Country (2024-2029) & (K Units)
    Table 42. APAC Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Medical Hemostatic Agents Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Medical Hemostatic Agents Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Medical Hemostatic Agents Sales in Volume by Country (2018-2023) & (K Units)
    Table 46. APAC Medical Hemostatic Agents Sales in Volume by Country (2024-2029) & (K Units)
    Table 47. J&J Company Information
    Table 48. J&J Description and Business Overview
    Table 49. J&J Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 50. J&J Medical Hemostatic Agents Product
    Table 51. J&J Recent Development
    Table 52. Baxter Company Information
    Table 53. Baxter Description and Business Overview
    Table 54. Baxter Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 55. Baxter Medical Hemostatic Agents Product
    Table 56. Baxter Recent Development
    Table 57. BD Company Information
    Table 58. BD Description and Business Overview
    Table 59. BD Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 60. BD Medical Hemostatic Agents Product
    Table 61. BD Recent Development
    Table 62. Gelita Company Information
    Table 63. Gelita Description and Business Overview
    Table 64. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 65. Gelita Medical Hemostatic Agents Product
    Table 66. Gelita Recent Development
    Table 67. Pfizer Company Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 70. Pfizer Medical Hemostatic Agents Product
    Table 71. Pfizer Recent Development
    Table 72. B Braun Company Information
    Table 73. B Braun Description and Business Overview
    Table 74. B Braun Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 75. B Braun Medical Hemostatic Agents Product
    Table 76. B Braun Recent Development
    Table 77. CSL Behring Company Information
    Table 78. CSL Behring Description and Business Overview
    Table 79. CSL Behring Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 80. CSL Behring Medical Hemostatic Agents Product
    Table 81. CSL Behring Recent Development
    Table 82. Ferrosan Medical Devices Company Information
    Table 83. Ferrosan Medical Devices Description and Business Overview
    Table 84. Ferrosan Medical Devices Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 85. Ferrosan Medical Devices Medical Hemostatic Agents Product
    Table 86. Ferrosan Medical Devices Recent Development
    Table 87. Advance Medical Solution Company Information
    Table 88. Advance Medical Solution Description and Business Overview
    Table 89. Advance Medical Solution Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 90. Advance Medical Solution Medical Hemostatic Agents Product
    Table 91. Advance Medical Solution Recent Development
    Table 92. Medtronic Company Information
    Table 93. Medtronic Description and Business Overview
    Table 94. Medtronic Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 95. Medtronic Medical Hemostatic Agents Product
    Table 96. Medtronic Recent Development
    Table 97. Z-Medica Company Information
    Table 98. Z-Medica Description and Business Overview
    Table 99. Z-Medica Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 100. Z-Medica Medical Hemostatic Agents Product
    Table 101. Z-Medica Recent Development
    Table 102. Marine Polymer Company Information
    Table 103. Marine Polymer Description and Business Overview
    Table 104. Marine Polymer Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 105. Marine Polymer Medical Hemostatic Agents Product
    Table 106. Marine Polymer Recent Development
    Table 107. Equimedical Company Information
    Table 108. Equimedical Description and Business Overview
    Table 109. Equimedical Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 110. Equimedical Medical Hemostatic Agents Product
    Table 111. Equimedical Recent Development
    Table 112. CryoLife Company Information
    Table 113. CryoLife Description and Business Overview
    Table 114. CryoLife Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 115. CryoLife Medical Hemostatic Agents Product
    Table 116. CryoLife Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Medical Hemostatic Agents Customers List
    Table 120. Medical Hemostatic Agents Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Medical Hemostatic Agents Product Picture
    Figure 2. Global Medical Hemostatic Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Medical Hemostatic Agents Market Size 2018-2029 (US$ Million)
    Figure 4. Global Medical Hemostatic Agents Sales 2018-2029 (K Units)
    Figure 5. India Medical Hemostatic Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Medical Hemostatic Agents Market Size 2018-2029 (US$ Million)
    Figure 7. India Medical Hemostatic Agents Sales 2018-2029 (K Units)
    Figure 8. India Medical Hemostatic Agents Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Medical Hemostatic Agents Market Share in Global, in Volume (K Units) 2018-2029
    Figure 10. Medical Hemostatic Agents Report Years Considered
    Figure 11. Product Picture of Gelation Hemostats
    Figure 12. Product Picture of Combination Hemostats
    Figure 13. Product Picture of Others
    Figure 14. Global Medical Hemostatic Agents Market Share by Type in 2022 & 2029
    Figure 15. Global Medical Hemostatic Agents Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 16. Global Medical Hemostatic Agents Sales Market Share in Value by Type (2018-2029)
    Figure 17. Global Medical Hemostatic Agents Sales by Type (2018-2029) & (K Units)
    Figure 18. Global Medical Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
    Figure 19. Global Medical Hemostatic Agents Price by Type (2018-2029) & (US$/Unit)
    Figure 20. India Medical Hemostatic Agents Market Share by Type in 2022 & 2029
    Figure 21. India Medical Hemostatic Agents Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 22. India Medical Hemostatic Agents Sales Market Share in Value by Type (2018-2029)
    Figure 23. India Medical Hemostatic Agents Sales by Type (2018-2029) & (K Units)
    Figure 24. India Medical Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
    Figure 25. India Medical Hemostatic Agents Price by Type (2018-2029) & (US$/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Surgical Centers
    Figure 28. Product Picture of Others
    Figure 29. Global Medical Hemostatic Agents Market Share by Application in 2022 & 2029
    Figure 30. Global Medical Hemostatic Agents Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 31. Global Medical Hemostatic Agents Sales Market Share in Value by Application (2018-2029)
    Figure 32. Global Medical Hemostatic Agents Sales by Application (2018-2029) & (K Units)
    Figure 33. Global Medical Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
    Figure 34. Global Medical Hemostatic Agents Price by Application (2018-2029) & (US$/Unit)
    Figure 35. India Medical Hemostatic Agents Market Share by Application in 2022 & 2029
    Figure 36. India Medical Hemostatic Agents Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 37. India Medical Hemostatic Agents Sales Market Share in Value by Application (2018-2029)
    Figure 38. India Medical Hemostatic Agents Sales by Application (2018-2029) & (K Units)
    Figure 39. India Medical Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
    Figure 40. India Medical Hemostatic Agents Price by Application (2018-2029) & (US$/Unit)
    Figure 41. Americas Medical Hemostatic Agents Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 42. Americas Medical Hemostatic Agents Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 43. Americas Medical Hemostatic Agents Sales by Type (2018-2029) & (K Units)
    Figure 44. Americas Medical Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
    Figure 45. Americas Medical Hemostatic Agents Sales by Application (2018-2029) & (K Units)
    Figure 46. Americas Medical Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
    Figure 47. United States Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Canada Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Mexico Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Brazil Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. EMEA Medical Hemostatic Agents Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 52. EMEA Medical Hemostatic Agents Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 53. EMEA Medical Hemostatic Agents Sales by Type (2018-2029) & (K Units)
    Figure 54. EMEA Medical Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
    Figure 55. EMEA Medical Hemostatic Agents Sales by Application (2018-2029) & (K Units)
    Figure 56. EMEA Medical Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
    Figure 57. Europe Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Middle East Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Africa Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. China Medical Hemostatic Agents Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 61. China Medical Hemostatic Agents Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 62. China Medical Hemostatic Agents Sales by Type (2018-2029) & (K Units)
    Figure 63. China Medical Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
    Figure 64. China Medical Hemostatic Agents Sales by Application (2018-2029) & (K Units)
    Figure 65. China Medical Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
    Figure 66. APAC Medical Hemostatic Agents Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 67. APAC Medical Hemostatic Agents Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 68. APAC Medical Hemostatic Agents Sales by Type (2018-2029) & (K Units)
    Figure 69. APAC Medical Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
    Figure 70. APAC Medical Hemostatic Agents Sales by Application (2018-2029) & (K Units)
    Figure 71. APAC Medical Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
    Figure 72. Japan Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. South Korea Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. China Taiwan Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. Southeast Asia Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. India Medical Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. Medical Hemostatic Agents Value Chain
    Figure 78. Medical Hemostatic Agents Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart